Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Cash Flow 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Cash Flow | -129.8M | -194.4M | -193.3M |
| Depreciation & Amort. | — | — | — |
| Investing Activities | |||
| Capital Expenditure | 31,000 | 2.6M | 4.6M |
| Free Cash Flow | -129.8M | -197.0M | -197.9M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Buybacks | — | — | — |
Inhibrx Biosciences, Inc. Cash Flow — FAQ
Inhibrx Biosciences, Inc. (INBX) cash flow over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's cash flow history?
The chart and table above show Inhibrx Biosciences, Inc.'s cash flow by year and by quarter, including the growth rate.